New Zovirax alternative approved

Alternative products are now commercially available to replace the recalled Zovirax ophthalmic ointment.

Recalled in October 2014 due to a potential for eye damage, Zovirax ophthalmic ointment left a gap in the market until the TGAZ granted authorisation to AciVision 30mg/g Aciclovir in late February 2015.

Now a second product, Virgan 0.15% w/w ganciclovir eye gel, has also been licensed by the